| Literature DB >> 24374381 |
Amber N V Ruigrok1, Gholamreza Salimi-Khorshidi2, Meng-Chuan Lai3, Simon Baron-Cohen4, Michael V Lombardo5, Roger J Tait6, John Suckling7.
Abstract
The prevalence, age of onset, and symptomatology of many neuropsychiatric conditions differ between males and females. To understand the causes and consequences of sex differences it is important to establish where they occur in the human brain. We report the first meta-analysis of typical sex differences on global brain volume, a descriptive account of the breakdown of studies of each compartmental volume by six age categories, and whole-brain voxel-wise meta-analyses on brain volume and density. Gaussian-process regression coordinate-based meta-analysis was used to examine sex differences in voxel-based regional volume and density. On average, males have larger total brain volumes than females. Examination of the breakdown of studies providing total volumes by age categories indicated a bias towards the 18-59 year-old category. Regional sex differences in volume and tissue density include the amygdala, hippocampus and insula, areas known to be implicated in sex-biased neuropsychiatric conditions. Together, these results suggest candidate regions for investigating the asymmetric effect that sex has on the developing brain, and for understanding sex-biased neurological and psychiatric conditions.Entities:
Keywords: Brain; Gaussian-process regression (GPR); Meta-analysis; Sex differences; Volume; Voxel-based morphometry
Mesh:
Year: 2013 PMID: 24374381 PMCID: PMC3969295 DOI: 10.1016/j.neubiorev.2013.12.004
Source DB: PubMed Journal: Neurosci Biobehav Rev ISSN: 0149-7634 Impact factor: 8.989
Studies included in the overall volumes meta-analyses.
| ID | Study | Year | Age | Volumes | |||
|---|---|---|---|---|---|---|---|
| Mean (SD) | Range | Category | |||||
| 1 | 2011 | 48 (21) | 40.5 | – | 4 | Cb | |
| 2 | 2008 | 53 (27) | – | 20–25 | 4 | Cbl | |
| 3 | 1991 | 24 (12) | 9.1 | 2–15 | 6 | Cb | |
| 122 (61) | 42 | 16–79 | 6 | ||||
| 4 | 2002 | 46 (23) | 32.4 | 22–49 | 4 | Cbl | |
| 5 | 2003 | 46 (23) | 32.4 | 22–49 | 4 | Cb, GM, WM | |
| 6 | 1994 | 90 (42) | 27.4 (10.3) | – | 4 | TBV, CSF, Cbl | |
| 7 | 2008 | 66 (32) | 34.1 | 23–51 | 4 | ICV, TBV, CSF | |
| 8 | 2010 | 60 (30) | 1 | 0–1 | 1 | TBV | |
| 9 | 2010 | 82 (34) | – | 33–35 | 4 | GM | |
| 10 | 2005 | 30 (15) | 28.8 | – | 4 | Cb, GM, WM | |
| 11 | 2003 | 30 (15) | 39.1 | – | 4 | TBV | |
| 12 | 2012 | 325 (173) | 10.9 | 4–18 | 3 | TBV, GM, WM, Cbl | |
| 13 | 2012 | 30 (15) | 30 | – | 4 | WM | |
| 14 | 2004 | 46 (25) | 10.9 | 6–17 | 3 | ICV, GM, WM | |
| 15 | 1995 | 44 (20) | 22.3 | 16–25 | 4 | ICV, TBV, GM | |
| 43 (24) | 30.8 | 26–35 | 4 | WM, CSF | |||
| 38 (22) | 40.9 | 36–45 | 4 | ||||
| 39 (24) | 50.6 | 46–55 | 4 | ||||
| 30 (15) | 60.2 | 56–65 | 4 | ||||
| 16 | 2007 | 27 (14) | 3.7 | 1–5 | 2 | ICV, TBV, GM, WM, Cbl | |
| 17 | 2008 | 117 (56) | 12.3 | 7–17 | 3 | GM | |
| 18 | 2005 | 91 (44) | 49.7 | – | 4 | ICV, Cb, GM, WM, CSF, Cbl | |
| 19 | 1999 | 37 (18) | 33.8 | 21–45 | 4 | ICV | |
| 20 | 2004 | 168 (88) | 29.1 | – | 4 | ICV | |
| 77 (57) | 76.8 | – | 5 | ||||
| 21 | 2006 | 97 (49) | 33.7 (13.6) | 15–69 | 6 | TBV, Cb, Cbl | |
| 22 | 1996 | 30 (15) | 9.2 | 7–11 | 3 | ICV, Cb, GM, WM, Cbl | |
| 23 | 2007 | 411 (227) | 46.7 | 44–48 | 4 | ICV, GM, WM, CSF | |
| 24 | 2012 | 27 (15) | 22.6 | – | 4 | TBV | |
| 25 | 2009 | 50 (25) | 27.1 | 19–50 | 4 | TBV, GM, WM | |
| 26 | 2010 | 43 (21) | 24.5 | – | 4 | ICV | |
| 27 | 2005 | 118 (60) | 23 (2.6) | – | 4 | Cbl | |
| 100 (59) | 47.5 (3.7) | – | 4 | ||||
| 28 | 2011 | 59 (34) | 11.5 (2.1) | 8–16 | 3 | ICV, WM | |
| 29 | 1998 | 330 (201) | 75 (5.1) | 66–96 | 5 | Cb | |
| 30 | 2003 | 30 (12) | 16.4 (1.7) | – | 3 | Cb | |
| 31 | 2000 | 116 (37) | 21.4 (20) | 1–80 | 6 | ICV | |
| 32 | 2007 | S, 18 (8) | 35.3 | 20–49 | 4 | ICV | |
| S, 16 (10) | 57.8 | 50–72 | 5 | ||||
| L, 19 (8) | 35.3 | 20–49 | 4 | ||||
| L, 15 (10) | 58.5 | 50–72 | 5 | ||||
| 33 | 2011 | 76 (31) | 28.1 | 15–51 | 4 | ICV, GM | |
| 34 | 2001 | 118 (57) | 11.9 | 6–17 | 3 | ICV, Cb, GM, WM | |
| 35 | 2005 | 1181 (233) | – | 34–54 | 4 | ICV | |
| 517 (288) | – | 55–61 | 4 | ||||
| 546 (275) | – | 62–70 | 5 | ||||
| 487 (272) | – | 71–96 | 5 | ||||
| 36 | 2005 | 30 (15) | 30 | – | 4 | ICV | |
| 37 | 2002 | 184 (121) | 79 | – | 5 | ICV | |
| 38 | 2001 | 85 (64) | 10.6 | – | 3 | Cb, GM, WM, CSF | |
| 40 | 2012 | 38 (20) | 8.4 | – | 3 | GM, WM, CSF | |
| 41 | 1994 | 20 (10) | 27.2 | 17–37 | 4 | TBV, Cb, GM, WM, Cbl | |
| 42 | 1999 | 30 (15) | 39.1 | 23–58 | 4 | TBV | |
| 43 | 2006 | 91 (51) | 20.1 | 18–33 | 4 | ICV, GM, WM, CSF | |
| 44 | 2002 | 54 (22) | 46.8 (19.3) | 20–86 | 6 | ICV, GM, WM | |
| 45 | 2007 | 74 (34) | 0.8 | 0.7–0.9 | 1 | ICV, Cbl | |
| 46 | 2001 | 48 (21) | 39.8 (11.4 | – | 4 | Cb, GM, WM | |
| 47 | 2001a | 465 (200) | 32 | 17–79 | 6 | GM, WM, CSF | |
| 48 | Guo | 2008 | 158 (80) | 15 (4.7) | 7–22 | 6 | ICV, GM, WM |
| 49 | Gur | 1991 | 69 (35) | 42.9 | 18–80 | 6 | TBV, CSF |
| 50 | Gur | 1999 | 80 (40) | 26 | 18–45 | 4 | ICV, TBV, GM, WM, CSF |
| 51 | Gur | 2002 | 116 (59) | 26 | 18–49 | 4 | ICV, GM, WM, CSF |
| 52 | 2010 | 43 (25) | 22.3 (2.5) | 19–32 | 4 | ICV, GM, WM, CSF | |
| 53 | 2011 | 228 (107) | 68.7 | 68–69 | 5 | ICV | |
| 54 | 2001 | 39 (19) | 40.8 | – | 6 | ICV, GM, WM | |
| 55 | 2012 | 3962 (2156) | 60.1 (8.5) | >45 | 6 | ICV | |
| 56 | 2003 | 120 (60) | 25.1 | – | 4 | TBV, Cbl | |
| 57 | 2000 | 52 (28) | 56.1 (12.1) | 36–85 | 6 | ICV | |
| 58 | 2004 | 24 (12) | 31.4 (8.9) | 21–53 | 4 | ICV | |
| 59 | 2009 | 76 (38) | 26.7 | 18–47 | 4 | Cb | |
| 60 | 2006 | 290 (145) | 24.2 | 18–32 | 4 | ICV, TBV, GM, WM, CSF | |
| 61 | – | 60 (30) | 27.9 | 18–49 | 4 | ICV, TBV, GM, WM, CSF | |
| 62 | 2004 | 41 (20) | 72.2 (7.3) | – | 5 | ICV | |
| 63 | 2004 | 62 (28) | – | 18–77 | 6 | ICV, GM, WM | |
| 64 | 2009a | 57 (29) | 24.4 | 20–28 | 4 | ICV, Cbl | |
| 58 (26) | 67.8 | 62–74 | 5 | ||||
| 65 | 2009b | 68 (39) | 21.7 (2.3) | 20–29 | 4 | ICV | |
| 66 | 2005 | 662 (331) | 69.5 | 63–75 | 5 | ICV, GM, WM, CSF | |
| 67 | 2012 | 86 (45) | 35.1 | 26–51 | 4 | ICV, TBV, GM, WM, CSF | |
| 68 | 2008 | 200 (100) | 21.6 | – | 4 | ICV, GM, WM, CSF, Cbl | |
| 69 | 2012 | 76 (38) | 43 | 19–70 | 6 | TBV, GM | |
| 70 | 2002 | 100 (50) | 24.7 | – | 4 | ICV, GM, WM, CSF | |
| 71 | 2003 | 59 (29) | 24.3 | – | 4 | ICV | |
| 72 | 2005 | 60 (30) | 24.8 | – | 4 | ICV, GM, WM, CSF | |
| 73 | 2006 | 150 (74) | 62.3 | 60–64 | 5 | TBV | |
| 74 | 2011 | 70 (35) | 54.5 | 20–87 | 6 | Cb | |
| 75 | 1996 | 12 (6) | – | 24–40 | 4 | ICV, TBV, | |
| 15 (5) | – | 41–60 | 4 | CSF | |||
| 22 (12) | – | 61–80 | 5 | ||||
| 76 | 2003 | 100 (56) | 32.6 (12.3) | 14–68 | 6 | Cb | |
| 77 | 2005 | 10 (5) | – | 20–29 | 4 | ICV, GM, | |
| 10 (5) | – | 30–39 | 4 | WM, CSF | |||
| 10 (5) | – | 40–49 | 4 | ||||
| 10 (5) | – | 50–59 | 4 | ||||
| 10 (5) | – | 60–69 | 5 | ||||
| 78 | 2007 | 65 (35) | 28.2 | – | 4 | ICV, GM, WM, CSF | |
| 79 | 2009 | 46 (23) | 11.3 | 8–15 | 3 | TBV | |
| 80 | 1997 | 80 (40) | 28.1 | – | 4 | TBV, CSF | |
| 81 | 2000 | 84 (42) | 23.3 | 19–31 | 4 | ICV, Cb, CSF, Cbl | |
| 82 | 2009 | 133 (73) | – | 29–80 | 6 | ICV, GM | |
| 83 | 1997 | 43 (30) | 53.7 | 24–82 | 6 | TBV, GM, WM | |
| 84 | 2010 | 419 (215) | 15.3 | – | 3 | ICV, GM, WM | |
| 85 | 2009 | 78 (41) | 11.9 | 10–14 | 3 | ICV, GM, WM, Cbl | |
| 86 | 2006 | 15 (6) | 24.2 | 16–50 | 4 | ICV, TBV, GM, WM | |
| 87 | 2007 | 49 (25) | 25.1 | – | 4 | GM, WM, CSF | |
| 88 | 2013 | 161 (74) | 0.03 | – | 1 | ICV | |
| 89 | 2011 | 38 (19) | 32.5 | – | 4 | ICV, GM, WM, CSF | |
| 90 | 2011 | 94 (33) | 15.4 (1.4) | 9–19 | 3 | ICV, GM, WM, CSF | |
| 91 | 1996 | 85 (64) | 10.6 | 5–17 | 3 | ICV, GM, WM, CSF | |
| 92 | 2004 | 31 (17) | 8.5 (0.7) | 7–11 | 3 | GM, WM, CSF | |
| 93 | 2000 | 116 (48) | 70.4 (7.5) | 59–85 | 5 | TBV, GM, WM | |
| 94 | 1999 | 20 (11) | – | 20–29 | 4 | Cbl | |
| 19 (9) | – | 30–39 | 4 | ||||
| 23 (13) | – | 40–49 | 4 | ||||
| 20 (10) | – | 50–59 | 4 | ||||
| 23 (12) | – | 60–69 | 5 | ||||
| 19 (12) | – | 70–79 | 5 | ||||
| 95 | 2005 | 133 (95) | – | ≤60 | 4 | ICV, GM, | |
| 96 (63) | – | >60 | 5 | WM | |||
| 96 | 2012 | 1004 (591) | 22.8 | 18–36 | 4 | GM, WM | |
| 97 | 2008 | 383 (172) | 62.7 | 60–64 | 5 | ICV | |
| 98 | 2012 | 108 (54) | 12.3 | 7–17 | 3 | Cb | |
| 99 | 2008 | 18 (10) | 13.8 (0.5) | – | 3 | ICV | |
| 100 | 2011 | 48 (24) | 34 | 26–48 | 4 | ICV, TBV, GM, WM | |
| 101 | 1995 | 60 (17) | 31.6 | – | 4 | ICV | |
| 102 | 1999 | 33 (15) | 2.1 | 0–4 | 2 | ICV | |
| 11 (3) | 8.1 | 5–9 | 3 | ICV | |||
| 24 (8) | 12.9 | 10–15 | 3 | ICV | |||
| 103 | 2005 | 13 (8) | 27.4 | – | 4 | TBV | |
| 13 (8) | 69.8 | – | 5 | ||||
| 104 | 2005 | 30 (15) | 27.2 | – | 4 | ICV | |
| 105 | 2008 | 30 (19) | 25.6 (7.7) | – | 4 | ICV | |
| 106 | 2007 | 176 (86) | 32.4 | 7–87 | 6 | ICV, GM, WM, CSF | |
| 107 | 2002 | 26 (8) | 4 (0.5) | 3–4 | 2 | Cb, Cbl | |
| 108 | 2001 | 92 (41) | 46.9 | 22–71 | 6 | ICV | |
| 109 | 2004 | 143 (48) | 49.3 | 20–85 | 6 | ICV | |
| 110 | 2005 | 128 (44) | – | 20–85 | 6 | ICV | |
| 111 | 2004 | 61 (31) | 24.5 (5.5) | 18–38 | 4 | ICV | |
| 112 | 2010 | 109 (58) | 26.3 | 21–29 | 4 | GM, WM | |
| 113 | 2010 | 29 (11) | 33 (9.1) | 20–55 | 4 | TBV | |
| 114 | 2012 | 27 (9) | – | 0–2 | 1 | TBV | |
| 34 (17) | – | 2–10 | 2 | ||||
| 48 (26) | – | 10–25 | 6 | ||||
| 115 | 2012 | 140 (70) | 20.9 | 18–26 | 4 | ICV, GM, WM, CSF | |
| 116 | 2001 | 55 (31) | – | 23–83 | 6 | ICV | |
| 117 | 2007 | 67 (34) | 7.6 | – | 3 | GM, WM | |
| 66 (34) | 11.1 | – | 3 | ||||
| 67 (34) | 15.6 | – | 3 | ||||
| 118 | 2010 | 34 (17) | 26.6 (5) | 21–47 | 4 | ICV, GM, WM, CSF | |
| 119 | 2008a | 60 (30) | 28.9 | 18–50 | 4 | ICV, GM | |
| 120 | 2008b | 74 (37) | 12.5 | 7–17 | 3 | ICV, Cb | |
| 121 | 2008 | 155 (66) | 28.5 | 21–40 | 4 | ICV, GM, WM, CSF | |
| 122 | 2008 | 57 (23) | 11.7 | 7–17 | 3 | ICV, GM, WM, CSF | |
| 123 | 1988 | 58 (29) | 56.3 (17.5) | 21–81 | 6 | ICV | |
| 124 | 2009 | O, 84 (60) | 65.1 | 47–75 | 5 | ICV, Cb | |
| B, 86 (60) | 59.3 | 46–77 | 5 | ||||
| 125 | 2002 | 30 (20) | 14.7 (1.5) | 13–17 | 3 | ICV, GM, WM | |
| 126 | 2007 | 24 (12) | 27.7 (4.4) | 17–35 | 4 | WM | |
| 12 (7) | 74.8 (2.6) | 72–80 | 5 | ||||
Abbreviations: B, Bergen; BDCG, brain development cooperative group; Cb, cerebrum (excluding CSF and Cbl); Cbl, cerebellum; CSF, cerebrospinal fluid; F, female; GM, grey matter; ICV, intracranial volume (including CSF); ID, identification number; L, Liverpool; N, number of participants; O, Oslo; S, Sheffield; SD, standard deviation; TBV, total brain volume (including Cbl but excluding CSF); WM, white matter.
Weighted mean and standard deviations.
Studies included in the regional meta-analyses.
| ID | Study | Year | Age | Volume | No. peak voxels | |||
|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Range | Category | ||||||
| 127 | 2009 | 55 (32) | ±31 | – | 4 | GM | 9 | |
| 23 | 2007 | 411 (227) | 46.7 | 44–48 | 4 | GM | 11 | |
| 25 | 2009 | 50 (25) | 27.1 | 19–50 | 4 | GM | 14 | |
| 128 | 2010 | 112 (46) | 24.7 | 18–33 | 4 | Cbl GM | 14 | |
| 47 | 2001a | 465 (200) | 32 | 17–79 | 6 | GM; WM | 18; 7 | |
| 48 | Guo | 2008 | 158 (80) | 15.3 (4.7) | 7–22 | 6 | GM | 14 |
| 61 | – | 60 (30) | 27.9 | 18–49 | 4 | GM; WM | 42; 18 | |
| 67 | 2012 | 86 (45) | 35.1 | 26–51 | 4 | GM; WM | 8; 2 | |
| 129 | 2012 | 217 (116) | 9.5 | 8–11 | 3 | GM | 31 | |
| 82 | 2009 | 133 (73) | – | 29–80 | 6 | GM | 32 | |
| 130 | 2010 | 28 (14) | 25.6 | – | 4 | GM | 25 | |
| 100 | 2011 | 48 (24) | 34 | 26–48 | 4 | GM; WM | 7; 3 | |
| 131 | 2009 | 117 (58) | 22.8 | 18–40 | 4 | GM & WM | 7 | |
| 118 | 2010 | 34 (17) | 26.6 (5) | 21–47 | 4 | GM | 18 | |
| 121 | 2008 | 155 (66) | 28.5 | 21–40 | 4 | GM | 12 | |
| 122 | 2008 | 57 (23) | 11.7 | 7–17 | 3 | GM | 2 | |
| 132 | 2010 | 40 (20) | – | 20–25 | 4 | GM; WM | 3; 3 | |
| 43 | 2006 | 91 (51) | 20.1 | 18–33 | 4 | GM | 14 | |
| 47 | 2001a | 465 (200) | 32 | 17–79 | 6 | WM | 9 | |
| 40 | 2012 | 38 (20) | 8.4 | – | 3 | GM; WM | 3; 1 | |
| 133 | 2010 | 46 (31) | – | 50–74 | 5 | GM | 11 | |
| 85 | 2009 | 78 (41) | 11.9 | 10–15 | 3 | GM | 17 | |
| 134 | 2011 | 91 (35) | 31.4 | 20–79 | 6 | GM | 15 | |
| 136 (81) | 65.7 | 5 | 4 | |||||
| 135 | 2001 | 81 (41) | 44.2 | 20–81 | 6 | GM | 3 | |
| 115 | 2012 | 140 (70) | 20.9 | 18–26 | 4 | GM | 16 | |
Notes: Study ID count corresponds to and continues on from Table 1.
Abbreviations: F, female; GM, Grey matter; ID, identification number; N, number of participants; No., number; SD, standard deviation; WM, white matter.
Weighted mean and standard deviations.
Fig. 1Flow diagram based on PRISMA statement (www.prisma-statement.org).
Results of the overall volumes meta-analyses.
| Volume | Analysis type | Outcome | Cohen's d | Percentage difference | CI 95% | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICV | 77 | 100 | 14,957 (48%) | FFX | 62.3 | 0 | M > F | 3.03 | 12% | 135.3 | 117.8–152.8 | <10−6 |
| TBV | 31 | 40 | 2532 (50%) | RFX | 92.8 | 57.9 | M > F | 2.1 | 10.8% | 131 | 92.1–170.0 | <10−6 |
| Cb | 22 | 24 | 1851 (54%) | FFX | 12.5 | 0 | M > F | 3.35 | 9.8% | 51.06 | 38.7–63.5 | <10−6 |
| GM | 60 | 71 | 7934 (52%) | FFX | 26.5 | 0 | M > F | 2.13 | 9.4% | 56.51 | 44.2–68.9 | <10−6 |
| WM | 57 | 69 | 7515 (52%) | FFX | 39.9 | 0 | M > F | 2.06 | 12.9% | 44.4 | 34.2–54.6 | <10−6 |
| CSF | 35 | 45 | 4484 (50%) | FFX | 15.5 | 0 | M > F | 1.21 | 11.5% | 18.72 | 9.6–27.8 | 3.2 × 10−5* |
| Cbl | 19 | 26 | 1842 (51%) | FFX | 9.7 | 0 | M > F | 1.68 | 8.6% | 7.78 | 4.2–11.4 | 1.4 × 10−5* |
Abbreviations: Cb, cerebrum; Cbl, cerebellum; CSF, cerebrospinal fluid; F, females; FFX, fixed effects model; GM, grey matter; I2, I2 index; ICV, intracranial volume; N, number of subjects; Q, Cochran's Q test; RFX, random effects model; TBV, total brain volume; WM, white matter.
Number of studies reporting the respective volumes.
Number of age-matched gender groups in the analysis (some studies provide more than one sample).
Number of females in percentages.
Values reported in mL.
Fig. 2Forest plot for the grey matter volume meta-analysis. Overview of all studies included in the grey matter volume meta-analysis. The square indicates the effect size in mL of each study (i.e. the difference in mL volume between males and females) and the bars indicate the 95% confidence interval of each study. The studies corresponding to the effect size can be found on the left. Study IDs correspond to the study IDs in Table 1. The diamond at the bottom of the figure indicates the meta-analytic effect size and its variance.
Fig. 3Breakdown by age categories for reports providing intracranial volume and grey matter volume. Three plots display the breakdown of studies examining intracranial volume (ICV) and grey matter volume (GM) in the current literature across six age categories: ‘infant’ (0–1 years), ‘early childhood’ (2–6 years), ‘late childhood’ (7–17 years), ‘mature’ (18–59 years), ‘senior’ (60+ years), and ‘lifespan’ (any study covering more than 2 age ranges): (a) the total number of articles providing ICV in each age category; (b) the sum of the total number of male and female participants included in those age categories; and (c) displays the weighted mean volumes of ICV and weighted error bars for males and females across all age categories. (d) The total number of articles providing GM in each age category; (e) the sum of the total number of male and female participants included in those age categories; and (f) displays the weighted mean volumes of GM and weighted error bars for males and females across all age categories.
Sex differences in GM volume and density.
| Region | Size | ||||
|---|---|---|---|---|---|
| Right amygdala, anterior parahippocampal gyrus, hippocampus, putamen and temporal pole | 824 | 7.29 | 28 | −2 | −34 |
| 6.89 | 26 | −6 | −20 | ||
| 5.71 | 26 | 10 | −6 | ||
| 5.2 | 26 | −14 | −26 | ||
| 4.83 | 22 | 6 | −12 | ||
| Left amygdala, anterior parahippocampal gyrus, hippocampus, putamen, temporal pole and orbitofrontal cortex | 611 | 8.76 | −16 | −4 | −26 |
| 5.17 | −36 | 4 | −18 | ||
| 5.67 | −28 | −12 | −18 | ||
| 5.07 | −20 | 10 | −16 | ||
| Left and right posterior cingulate gyrus and precuneus | 225 | 6.26 | −4 | −48 | 30 |
| 5.35 | 8 | −50 | 24 | ||
| 4.94 | 12 | −56 | 32 | ||
| Left cerebellum, VI, VIIb, VIIIa and Crus I | 210 | 7.82 | −28 | −60 | −32 |
| 4.45 | −28 | −48 | −36 | ||
| 4.3 | −20 | −66 | −46 | ||
| Left anterior and posterior cingulate gyrus and precentral gyrus | 117 | 5.93 | −2 | −6 | 44 |
| 5.74 | −2 | −18 | 46 | ||
| Left temporal pole | 123 | 5.68 | −46 | 10 | −42 |
| 4.69 | −50 | 16 | −30 | ||
| 3.91 | −44 | 24 | −30 | ||
| Right cerebellum, VIIb, VIIIa and Crus I and II | 100 | 5.12 | 40 | −52 | −56 |
| 4.37 | 32 | −64 | −42 | ||
| 4.14 | 28 | −56 | −46 | ||
| Left cerebellum VIIIa and VIIb | 71 | 5.17 | −34 | −48 | −54 |
| Right frontal pole | 66 | 5.33 | 10 | 60 | 34 |
| Left temporal pole | 60 | 5.29 | −48 | −70 | −20 |
| Right inferior frontal gyrus, pars triangularis and pars opercularis, middle frontal gryus, frontal pole | 238 | 7.28 | 54 | 34 | 18 |
| 5.79 | 46 | 36 | 18 | ||
| 5.34 | 52 | 28 | 28 | ||
| 4.59 | 56 | 20 | 22 | ||
| Left and right thalami | 182 | 6.01 | −10 | −8 | 16 |
| 5.63 | −4 | −4 | 10 | ||
| 5.41 | 6 | −4 | 8 | ||
| Right parietal operculum cortex and planum temporale | 115 | 6.66 | 54 | −28 | 18 |
| 5.89 | 54 | −28 | 18 | ||
| Right anterior cingulate gyrus | 85 | 5.85 | 8 | 26 | 22 |
| Left and right precuneus | 79 | 5.14 | −2 | −60 | 60 |
| 4.87 | 4 | −52 | 64 | ||
| Right frontal orbital cortex | 67 | 5.07 | 22 | 24 | −20 |
| 5 | 20 | 28 | −24 | ||
| 4.9 | 28 | 26 | −20 | ||
| Left posterior parahippocampal gyrus | 66 | 6.92 | −14 | −36 | −6 |
| Left lateral occipital cortex, superior division | 64 | 5.92 | −38 | −78 | 32 |
| Right insular cortex and Heschl's gyrus | 63 | 5.78 | 32 | −22 | 6 |
| 5.27 | 38 | −22 | 8 | ||
| Left amygdala, hippocampus, insula, pallidum, putamen, claustrum | 475 | 6.42 | −20 | −12 | −22 |
| 6.26 | −36 | −6 | 12 | ||
| 5.78 | −26 | −10 | 2 | ||
| 5.29 | −22 | −14 | −6 | ||
| 4.56 | −30 | −18 | 12 | ||
| 4.08 | −34 | −6 | −24 | ||
| Right cerebellum VI | 81 | 6.86 | 32 | −52 | −30 |
| Left frontal pole | 64 | 7.28 | −14 | 38 | −24 |
Abbreviations: GM, grey matter; MNI, Montreal Neurological Institute.
Size in 2 mm voxels on MNI152_T1_2mmbrain mask.
Values were thresholded at qFDR < 0.01 for GM volume, which is equal to Z > 3.44 for M > F and Z > 3.62 for F > M, and at qFDR < 0.05 for GM density, which is equal to Z > 3.25 for M > F and Z > 3.44 for F > M. With a minimum cluster size of 60 voxels. The MNI coordinates indicate the value of the peak voxel and local minima of the cluster and the size the span of the cluster.
Fig. 4Voxel-based regional sex differences in grey matter volume. Female > Male in red, and Male > Female is in blue. Panel a, rendered overview of uncorrected regional sex differences in grey matter volume. All other panels are thresholded at FDR q < 0.01. Panels b–f display areas of larger volume in females (red) including (b) the right inferior and middle frontal gyri, pars triangularis and planum temporale; (c) thalamus and right anterior cingulate gyrus; and (f) left and right thalamus; and areas of larger volume in males (blue), including (c) the anterior cingulate gyrus; (d) bilateral posterior cingulate gyrus and precuneus and left cerebellum; (e) anterior and posterior cingulate gyri; and (f) left and right amygdalae, hippocampi and parahippocampal gyri.
Fig. 5Voxel-based regional sex differences in grey matter density. Female > Male in red, and Male > Female is in blue. Panel a, rendered overview of uncorrected regional sex differences in grey matter concentration. All other panels are thresholded at FDR q < 0.05. Panels b–c display areas of larger volume in females (red) in (b) frontal pole and (c) right thalamus; and in males (blue) including (c) left amygdala, hippocampus, insular cortex and putamen; (d) right and left cerebellum VI lobe.